RP-6306
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for RP-6306, covering 2025-08-20 to 2026-02-06. Get the full timeline:
Most recent: Clinical Trial Update: RP-6306 in Patients With Advanced Cancer [Phase 2]